Phaarmasia Ltd vs Procter Gamble Health Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Phaarmasia Ltd is ₹ 98.16 as of 05 May 15:30 . The p/e ratio of Phaarmasia Ltd changed from 54 to 0 over 4 quarters. This represents a CAGR of -100.00% The p/e ratio of Procter & Gamble Health Ltd changed from 52.5 to 0 over 9 quarters. This represents a CAGR of -100.00% The market cap of Phaarmasia Ltd changed from ₹ 20.02 crore to ₹ 19.88 crore over 5 quarters. This represents a CAGR of -0.56% The market cap of Procter & Gamble Health Ltd changed from ₹ 9285 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The revenue of Phaarmasia Ltd for the Dec '25 is ₹ 35.21 crore as compare to the Sep '25 revenue of ₹ 16.69 crore. This represent the growth of 110.96% The revenue of Procter & Gamble Health Ltd for the Dec '25 is ₹ 378.22 crore as compare to the Sep '25 revenue of ₹ 329.87 crore. This represent the growth of 14.66% The ebitda of Phaarmasia Ltd for the Dec '25 is ₹ 19.99 crore as compare to the Sep '25 ebitda of ₹ 1.75 crore. This represent the growth of 1042% The ebitda of Procter & Gamble Health Ltd for the Dec '25 is ₹ 114.82 crore as compare to the Sep '25 ebitda of ₹ 125.22 crore. This represent the decline of -8.31% The net profit of Phaarmasia Ltd changed from ₹ -0.7 crore to ₹ 16.27 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Procter & Gamble Health Ltd changed from ₹ 46.56 crore to ₹ 77.59 crore over 7 quarters. This represents a CAGR of 33.89% The dividend payout of Phaarmasia Ltd changed from 0 % to 0 % over 9 quarters. This represents a CAGR of 0.0% The dividend payout of Procter & Gamble Health Ltd changed from 122.06 % to 0 % over 9 quarters. This represents a CAGR of -100.00% .

About Phaarmasia Ltd

Incorporated in 1981, Phaarmasia Limited (unit-I) is the part of the Maneesh Pharmaceutical Limited, with its headquarters and marketing office in Mumbai.
M/s Phaarmasia Limited Unit-II was established in 1993-94.
The Company is engaged in manufacturing and marketing of Oral contraceptive tablets' with various therapeutic dosage combinations along with iron tablets for Ministry of Health & Family Welfare and for Exports. The plant is situated in a hygienic environment; free from dust, smoke, chemical & biological emission.
Phaarmasia Ltd. Is an independent State-of-the-art-manufacturing unit having manufacturing facility of international standards with manufacturing capacity of more than 30 million units per annum. During the year 2000, the company became a Sick Industrial Company under SICA and therefore the same was referred to the BIFR.

About Procter & Gamble Health Ltd

Procter & Gamble Health Limited was erstwhile incorporated as E Merck (India) Limited in 1967.
The Company's name was changed from E Merck (India) Limited to Merck Limited on March 27, 2002.
Later, the name of the Company was changed to Procter & Gamble Health Limited on 6 May, 2019.
The company was set up to take over the business of the Indian branch of Emeda Exports with all their assets and liabilities.
The company is a 51% subsidiary of German firm Merck KGaA, is a leading player in vitamin formulations. Procter & Gamble Health Limited is an Indian-based company principally engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.

FAQs for the comparison of Phaarmasia Ltd and Procter & Gamble Health Ltd

Which company has a larger market capitalization, Phaarmasia Ltd or Procter & Gamble Health Ltd?

Market cap of Phaarmasia Ltd is 67 Cr while Market cap of Procter & Gamble Health Ltd is 8,566 Cr

What are the key factors driving the stock performance of Phaarmasia Ltd and Procter & Gamble Health Ltd?

The stock performance of Phaarmasia Ltd and Procter & Gamble Health Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Phaarmasia Ltd and Procter & Gamble Health Ltd?

As of May 5, 2026, the Phaarmasia Ltd stock price is INR ₹98.16. On the other hand, Procter & Gamble Health Ltd stock price is INR ₹5160.9.

How do dividend payouts of Phaarmasia Ltd and Procter & Gamble Health Ltd compare?

To compare the dividend payouts of Phaarmasia Ltd and Procter & Gamble Health Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.